Verucopeptin, a new antitumor antibiotic active against B16 melanoma. I. Taxonomy, production, isolation, physico-chemical properties and biological activity. 1993

Y Nishiyama, and K Sugawara, and K Tomita, and H Yamamoto, and H Kamei, and T Oki
Bristol-Myers Squibb Research Institute, Tokyo, Japan.

A new antitumor antibiotic verucopeptin was isolated from the culture broth of Actinomadura verrucosospora Q886-2. It should potent cytotoxicity and specific in vivo activity against B16 melanoma. Maximum T/C value (162%) was obtained by Q1D x 1 treatment schedule.

UI MeSH Term Description Entries
D007939 Leukemia L1210 An experimental LYMPHOCYTIC LEUKEMIA of mice. Leukemia L 1210,L 1210, Leukemia,L1210, Leukemia
D007941 Leukemia P388 An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene. P388D(1) Leukemia,P388, Leukemia
D008297 Male Males
D008546 Melanoma, Experimental Experimentally induced tumor that produces MELANIN in animals to provide a model for studying human MELANOMA. B16 Melanoma,Melanoma, B16,Melanoma, Cloudman S91,Melanoma, Harding-Passey,Experimental Melanoma,Experimental Melanomas,Harding Passey Melanoma,Melanomas, Experimental,B16 Melanomas,Cloudman S91 Melanoma,Harding-Passey Melanoma,Melanoma, Harding Passey,Melanomas, B16,S91 Melanoma, Cloudman
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010456 Peptides, Cyclic Peptides whose amino acid residues are linked together forming a circular chain. Some of them are ANTI-INFECTIVE AGENTS; some are biosynthesized non-ribosomally (PEPTIDE BIOSYNTHESIS, NON-RIBOSOMAL). Circular Peptide,Cyclic Peptide,Cyclic Peptides,Cyclopeptide,Orbitide,Circular Peptides,Cyclopeptides,Orbitides,Peptide, Circular,Peptide, Cyclic,Peptides, Circular
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D005285 Fermentation Anaerobic degradation of GLUCOSE or other organic nutrients to gain energy in the form of ATP. End products vary depending on organisms, substrates, and enzymatic pathways. Common fermentation products include ETHANOL and LACTIC ACID. Fermentations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000192 Actinomycetales An order of gram-positive, primarily aerobic BACTERIA that tend to form branching filaments. Corynebacteriaceae,Coryneform Group

Related Publications

Y Nishiyama, and K Sugawara, and K Tomita, and H Yamamoto, and H Kamei, and T Oki
June 1993, The Journal of antibiotics,
Y Nishiyama, and K Sugawara, and K Tomita, and H Yamamoto, and H Kamei, and T Oki
August 1991, The Journal of antibiotics,
Y Nishiyama, and K Sugawara, and K Tomita, and H Yamamoto, and H Kamei, and T Oki
July 1988, The Journal of antibiotics,
Y Nishiyama, and K Sugawara, and K Tomita, and H Yamamoto, and H Kamei, and T Oki
November 2003, The Journal of antibiotics,
Y Nishiyama, and K Sugawara, and K Tomita, and H Yamamoto, and H Kamei, and T Oki
February 1980, The Journal of antibiotics,
Y Nishiyama, and K Sugawara, and K Tomita, and H Yamamoto, and H Kamei, and T Oki
August 1997, The Journal of antibiotics,
Y Nishiyama, and K Sugawara, and K Tomita, and H Yamamoto, and H Kamei, and T Oki
December 2003, The Journal of antibiotics,
Y Nishiyama, and K Sugawara, and K Tomita, and H Yamamoto, and H Kamei, and T Oki
January 1998, The Journal of antibiotics,
Y Nishiyama, and K Sugawara, and K Tomita, and H Yamamoto, and H Kamei, and T Oki
November 1994, The Journal of antibiotics,
Y Nishiyama, and K Sugawara, and K Tomita, and H Yamamoto, and H Kamei, and T Oki
November 1989, The Journal of antibiotics,
Copied contents to your clipboard!